Ultomiris 300 mg/30 mL (10 mg/mL) injection Images
Generic Name: ravulizumab
This medication has been identified as Ultomiris 300 mg/30 mL (10 mg/mL) injection and is used for Myasthenia Gravis, Neuromyelitis Optica Spectrum Disorder, Hemolytic Uremic Syndrome, and Paroxysmal Nocturnal Hemoglobinuria. It belongs to the drug class selective immunosuppressants and is not a controlled substance.
Images of medication
Ultomiris
- Generic Name
- ravulizumab
- Strength
- 300 mg/30 mL (10 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Alexion Pharmaceuticals Inc.
- National Drug Code (NDC)
- 25682-0022 (Discontinued)
See also:
More about Ultomiris (ravulizumab)
- Check interactions
- Compare alternatives
- Reviews (8)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.